目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Digital Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Digital Therapeutics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Digital Therapeutics Market: Application Estimates & Trend Analysis
4.1. Application Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Digital Therapeutics Market by Application Outlook
4.4. Diabetes
4.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.5. Obesity
4.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.6. Cardiovascular Disease (CVD)
4.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.7. Respiratory Diseases
4.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.8. Smoking Cessation
4.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.9. Central Nervous System (CNS) Disease
4.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.10. Others
4.10.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. Digital Therapeutics Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Digital Therapeutics Market by End Use Outlook
5.4. Patients
5.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.5. Providers
5.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.6. Payers
5.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.7. Employers
5.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.8. Others
5.8.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 6. Digital Therapeutics Market: Regional Estimates & Trend Analysis, By Application, By End Use
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
6.6.6. Denmark
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
6.6.8. Norway
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/ reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Company Profiles
7.3.1. OMADA HEALTH, INC.
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Welldoc, Inc.
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. 2Morrow, Inc
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Livongo Health, Inc. (Teladoc Health, Inc.)
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Propeller Health (ResMed)
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Fitbit LLC
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Mango Health
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. CANARY HEALTH
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Noom, Inc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Pear Therapeutics, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Akili Interactive Labs, Inc.
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. HYGIEIA
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. DarioHealth Corp.
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. BigHealth
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
7.3.15. GAIA AG
7.3.15.1. Company overview
7.3.15.2. Financial performance
7.3.15.3. Product benchmarking
7.3.15.4. Strategic initiatives
7.3.16. Limbix Health, Inc.
7.3.16.1. Company overview
7.3.16.2. Financial performance
7.3.16.3. Product benchmarking
7.3.16.4. Strategic initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 4 North America digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 5 North America digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 6 U.S. macro dynamics
Table 7 U.S. digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 8 U.S. digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 9 Canada macro dynamics
Table 10 Canada digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 11 Canada digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 12 Mexico macro dynamics
Table 13 Mexico digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 14 Mexico digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 15 Europe digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 16 Europe digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 17 Europe digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 18 UK macro dynamics
Table 19 UK digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 20 UK digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 21 Germany macro dynamics
Table 22 Germany digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 23 Germany digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 24 France macro dynamics
Table 25 France digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 26 France digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 27 Italy macro dynamics
Table 28 Italy digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 29 Italy digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 30 Spain macro dynamics
Table 31 Spain digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 32 Spain digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 33 Denmark macro dynamics
Table 34 Denmark digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 35 Denmark digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 36 Sweden macro dynamics
Table 37 Sweden digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 38 Sweden digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 39 Norway macro dynamics
Table 40 Norway digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 41 Norway digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 42 Asia Pacific digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 43 Asia Pacific digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 44 Asia Pacific digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 45 Asia Pacific digital therapeutics market estimates and forecasts, by therapeutic application, 2018 - 2030 (USD Million)
Table 46 Japan macro dynamics
Table 47 Japan digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 48 Japan digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 49 China macro dynamics
Table 50 China digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 51 China digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 52 India macro dynamics
Table 53 India digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 54 India digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 55 Australia Macro dynamics
Table 56 Australia digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 57 Australia digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 58 Thailand macro dynamics
Table 59 Thailand digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 60 Thailand digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 61 South Korea macro dynamics
Table 62 South Korea digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 63 South Korea digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 64 Latin America digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 65 Latin America digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 66 Latin America digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 67 Brazil macro dynamics
Table 68 Brazil digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 69 Brazil digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 70 Argentina macro dynamics
Table 71 Argentina digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 72 Argentina digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 73 MEA digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 74 MEA digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 75 MEA digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 76 South Africa macro dynamics
Table 77 South Africa digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 78 South Africa digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 79 Saudi Arabia Macro dynamics
Table 80 Saudi Arabia digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 82 UAE Macro dynamics
Table 83 UAE digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 84 UAE digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 85 Kuwait Macro dynamics
Table 86 Kuwait digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 87 Kuwait digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 88 Key company heat map analysis/company position analysis

List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Estimation methodology
Fig. 4 Data triangulation techniques
Fig. 5 Primary research pattern
Fig. 6 Market research approaches
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD modeling for market share assessment
Fig. 9 Market formulation & validation
Fig. 10 Commodity flow analysis
Fig. 11 Digital therapeutics market snapshot, 2023 (USD Million)
Fig. 12 Segment snapshot
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook
Fig. 15 Ancillary market outlook
Fig. 16 Digital Therapeutics market dynamics
Fig. 17 Digital therapeutics market driver impact
Fig. 18 Annual cost per person (USD) for key chronic conditions & by no. of co-morbidities
Fig. 19 Top countries by smartphone users, 2021
Fig. 20 Digital therapeutics market restraint impact
Fig. 21 Market participation categorization
Fig. 22 Market leaders and innovators
Fig. 23 Company market position analysis
Fig. 24 Major deals & strategic alliances analysis
Fig. 25 Digital therapeutics market: Application movement analysis
Fig. 26 Digital therapeutics Market: Application dashboard
Fig. 27 Global diabetes market, 2018 - 2030 (USD Million)
Fig. 28 Global obesity market, 2018 - 2030 (USD Million)
Fig. 29 Global CVD market, 2018 - 2030 (USD Million)
Fig. 30 Global respiratory diseases market, 2018 - 2030 (USD Million)
Fig. 31 Global smoking cessation market, 2018 - 2030 (USD Million)
Fig. 32 Global CNS diseases market, 2018 - 2030 (USD Million)
Fig. 33 Global others market, 2018 - 2030 (USD Million)
Fig. 34 Digital therapeutics market: End use movement analysis
Fig. 35 Digital therapeutics market: End use dashboard
Fig. 36 Global patients market, 2018 - 2030 (USD Million)
Fig. 37 Global providers market, 2018 - 2030 (USD Million)
Fig. 38 Global payers market, 2018 - 2030 (USD Million)
Fig. 39 Global employers market, 2018 - 2030 (USD Million)
Fig. 40 Global other end uses market, 2018 - 2030 (USD Million)
Fig. 41 Regional marketplace: Key takeaways
Fig. 42 North America: SWOT analysis
Fig. 43 North America digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 44 U.S. digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 45 Canada digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 46 Mexico digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 47 Europe: SWOT analysis
Fig. 48 Europe digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 49 UK digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 50 Germany digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 51 France digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 52 Italy digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 53 Spain digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 54 Sweden digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 55 Norway digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 56 Denmark digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 57 Asia Pacific: SWOT analysis
Fig. 58 Asia Pacific Digital Therapeutics market, 2018 - 2030 (USD Million)
Fig. 59 Japan digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 60 China digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 61 India digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 62 Australia digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 South Korea digital therapeutics market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 64 Thailand digital therapeutics market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 65 Latin America: SWOT analysis
Fig. 66 Latin America digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 67 Mexico digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 68 Brazil digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 69 Argentina digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 70 Middle East and Africa: SWOT analysis
Fig. 71 Middle East and Africa digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 72 South Africa digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 73 Saudi Arabia digital therapeutics market, 2018 - 2030 (USD Million)
Fig. 74 UAE digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Kuwait digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Heat map analysis
Fig. 77 List of key emerging companies/technology disruptors/innovators